These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15494372)

  • 1. Cells release prions in association with exosomes.
    Fevrier B; Vilette D; Archer F; Loew D; Faigle W; Vidal M; Laude H; Raposo G
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9683-8. PubMed ID: 15210972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion protein E219K polymorphism: from the discovery of the KANNO blood group to interventions for human prion disease.
    Wang SS; Meng ZL; Zhang YW; Yan YS; Li LB
    Front Neurol; 2024; 15():1392984. PubMed ID: 39050130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HIV-1 Tat on the formation of the mitotic spindle by interaction with ribosomal protein S3.
    Kim J; Kim YS
    Sci Rep; 2018 Jun; 8(1):8680. PubMed ID: 29875444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the key to the resistance of canids to prion diseases.
    Fernández-Borges N; Parra B; Vidal E; Eraña H; Sánchez-Martín MA; de Castro J; Elezgarai SR; Pumarola M; Mayoral T; Castilla J
    PLoS Pathog; 2017 Nov; 13(11):e1006716. PubMed ID: 29131852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dominant-negative mutant inhibits multiple prion variants through a common mechanism.
    Pei F; DiSalvo S; Sindi SS; Serio TR
    PLoS Genet; 2017 Oct; 13(10):e1007085. PubMed ID: 29084237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion diseases and adult neurogenesis: how do prions counteract the brain's endogenous repair machinery?
    Relaño-Ginés A; Lehmann S; Crozet C
    Prion; 2014; 8(3):240-6. PubMed ID: 24831876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein.
    Kim J; Yoon JH; Kim YS
    PLoS One; 2013; 8(11):e77972. PubMed ID: 24312169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing early misfolding events in prion protein mutants by NMR spectroscopy.
    Giachin G; Biljan I; Ilc G; Plavec J; Legname G
    Molecules; 2013 Aug; 18(8):9451-76. PubMed ID: 23966072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases.
    Relaño-Ginès A; Gabelle A; Hamela C; Belondrade M; Casanova D; Mourton-Gilles C; Lehmann S; Crozet C
    PLoS Pathog; 2013; 9(8):e1003485. PubMed ID: 23935493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.
    DiSalvo S; Serio TR
    Prion; 2011; 5(2):76-83. PubMed ID: 21654204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant prion mutants induce curing through pathways that promote chaperone-mediated disaggregation.
    DiSalvo S; Derdowski A; Pezza JA; Serio TR
    Nat Struct Mol Biol; 2011 Apr; 18(4):486-92. PubMed ID: 21423195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous inhibition in prion infection: the stone fence model.
    Kobayashi A; Hizume M; Teruya K; Mohri S; Kitamoto T
    Prion; 2009; 3(1):27-30. PubMed ID: 19372732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in prion chemotherapeutics.
    Sim VL; Caughey B
    Infect Disord Drug Targets; 2009 Feb; 9(1):81-91. PubMed ID: 19200018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X.
    Lee CI; Yang Q; Perrier V; Baskakov IV
    Protein Sci; 2007 Oct; 16(10):2166-73. PubMed ID: 17766375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
    Crozet C; Lin YL; Mettling C; Mourton-Gilles C; Corbeau P; Lehmann S; Perrier V
    J Cell Sci; 2004 Nov; 117(Pt 23):5591-7. PubMed ID: 15494372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective gene therapy in a mouse model of prion diseases.
    Toupet K; Compan V; Crozet C; Mourton-Gilles C; Mestre-Francés N; Ibos F; Corbeau P; Verdier JM; Perrier V
    PLoS One; 2008 Jul; 3(7):e2773. PubMed ID: 18648643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.